BETA - Summer - 2000Important note: Information in this article was accurate in June 2000. The state of the art may have changed since the publication date.
Click here to return to BETA main menu

Women and HIV/AIDS: Key Facts And Issues

Bulletin of Experimental Treatments for AIDS, Summer, 2000
 


Facts and figures


Modes of transmission

The AIDS epidemic in women is overwhelmingly heterosexual; this is almost entirely so in Africa and in South and Southeast Asia.

In other areas, a proportion of women are infected through:


Why are women more vulnerable to HIV infection?

Several factors make women more vulnerable than men to sexual infection with HIV.

Biologically

Economically

Socially and culturally


Why must the response be gender-based?

There are three main reasons for a gender-based response:

  1. Unequal gender relations, with powerful social, economic, and political dimensions, are driving the HIV epidemic, i.e., contributing to the spread of HIV infection.

  2. Women are disproportionately affected by the epidemic. Again, they are highly vulnerable to infection. Women often are forced to bear the psychosocial and physical burden of AIDS care. Women also suffer particular discrimination -- they are often blamed for spreading infection and become targets for anger and violence.

  3. Gender differences exist in HIV/AIDS pathology. Clinical management of HIV disease (based too often on research undertaken in men) must be responsive to women's particular needs, symptoms, types of HIV-related illnesses, and so forth.


What will make a difference?

Physical and material independence and security for women that is independent of the "protection" of a man or men is necessary. Women must be empowered to control their own lives and in particular their sexuality, and men must participate in this process (primarily by responding with respect). This implies a profound shift in social and economic power relations between men and women. Such a shift cannot be achieved immediately but action must start now, through:


Microbicides: our best hope

The development of a prevention method that is widely affordable, safe, effective, and under women's control is essential.


Proven effective interventions

A number of proven interventions comprise key strategies to control the spread of the epidemic. These strategies, which must be used in combination, are particularly important for women.

Treatment and prevention of sexually transmissible infection

Safe blood

Women and children are the chief recipients of blood transfusions, related to childbirth and frequently given during and after delivery. The following action is required:

Education for prevention including the use of condoms

Condoms, of both the so-called male and female varieties, are currently the only protection methods available. They need to be more widely accepted, available, and used.

It has been shown that even in the most favourable circumstances, male and female condom use is low. The acceptability of these methods remains problematic. The female condom is often felt to be more cumbersome than the male condom and considerably more expensive. Furthermore, women cannot insist upon or control the use of female condoms, either. Impact will continue to be low if people's preferences and therefore their actual sexual practices and use of methods are not given due attention.

Women as caregivers

Women often are forced to take full responsibility for the health care of all family members.

Involving men -- making them more responsible


This article was adapted from the World Health Organization (WHO) Fact Sheet No. 242.

For further information, journalists may contact:
Office of the Spokesperson
WORLD HEALTH ORGANIZATION
Avenue Appia 20
1211 Geneva 27
Switzerland
Telephone: 41-22-791-2599 Fax 41-22-791-4858
E-mail: inf@who.int
All WHO Press Releases, Fact Sheets, and Features as well as other information on this subject can be obtained online at www.who.int.

000610
BE000603


Copyright © 2000 - San Francisco AIDS Foundation. Reproduced by permission. Reproduction of this article (other than one copy for personal reference) must be cleared through BETA: PO Box 426182, San Francisco, CA 94142-6182. Tel: 415 487 8060 Fax: 415 487 8069 URL: http://www.sfaf.org/beta E-mail: beta@sfaf.org

ÆGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.